{"id":"https://openalex.org/W2065338378","doi":"https://doi.org/10.1182/blood-2011-11-390989","title":"The clinically active BTK inhibitor PCI-32765 targets B-cell receptor\u2013 and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia","display_name":"The clinically active BTK inhibitor PCI-32765 targets B-cell receptor\u2013 and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia","publication_year":2012,"publication_date":"2012-01-26","ids":{"openalex":"https://openalex.org/W2065338378","doi":"https://doi.org/10.1182/blood-2011-11-390989","mag":"2065338378","pmid":"https://pubmed.ncbi.nlm.nih.gov/22279054"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2011-11-390989","doi":"https://doi.org/10.1182/blood-2011-11-390989","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2011-11-390989","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081785697","display_name":"Martin F. M. de Rooij","orcid":"https://orcid.org/0000-0001-9224-3832","observed_orcids":["https://orcid.org/0000-0001-9224-3832"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin F. M. de Rooij","raw_affiliation_strings":["Departments of Pathology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pathology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018890341","display_name":"Annemieke Kuil","orcid":"https://orcid.org/0000-0002-8157-7412","observed_orcids":["https://orcid.org/0000-0002-8157-7412"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annemieke Kuil","raw_affiliation_strings":["Departments of Pathology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pathology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024670154","display_name":"Christian R. Geest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Christian R. Geest","raw_affiliation_strings":["Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044751799","display_name":"Eric Eldering","orcid":"https://orcid.org/0000-0003-0561-6640","observed_orcids":["https://orcid.org/0000-0003-0561-6640"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Eric Eldering","raw_affiliation_strings":["Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; and","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062625211","display_name":"Betty Y Chang","orcid":"https://orcid.org/0009-0000-6363-2484","observed_orcids":["https://orcid.org/0009-0000-6363-2484"]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betty Y. Chang","raw_affiliation_strings":["Pharmacyclics Inc, Sunnyvale, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics Inc, Sunnyvale, CA","institution_ids":["https://openalex.org/I4210133061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068953821","display_name":"Joseph J. Buggy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133061","display_name":"Pharmacyclics (United States)","ror":"https://ror.org/03hm8w204","country_code":"US","type":"company","lineage":["https://openalex.org/I4210133061"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph J. Buggy","raw_affiliation_strings":["Pharmacyclics Inc, Sunnyvale, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacyclics Inc, Sunnyvale, CA","institution_ids":["https://openalex.org/I4210133061"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032324734","display_name":"Steven T. Pals","orcid":"https://orcid.org/0000-0002-1419-0939","observed_orcids":["https://orcid.org/0000-0002-1419-0939"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Steven T. Pals","raw_affiliation_strings":["Departments of Pathology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pathology and","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035092788","display_name":"Marcel Spaargaren","orcid":"https://orcid.org/0000-0002-3135-5109","observed_orcids":["https://orcid.org/0000-0002-3135-5109"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Marcel Spaargaren","raw_affiliation_strings":["Departments of Pathology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pathology and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5032324734","https://openalex.org/A5035092788"],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":42.7287,"has_fulltext":false,"cited_by_count":578,"citation_normalized_percentile":{"value":0.99882345,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"119","issue":"11","first_page":"2590","last_page":"2594"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.7649999856948853},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9350000023841858},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.8650000095367432},{"id":"https://openalex.org/keywords/integrin-alpha4beta1","display_name":"alpha4beta1 integrin","score":0.8650000095367432},{"id":"https://openalex.org/keywords/lymphocyte-adhesion","display_name":"lymphocyte adhesion","score":0.8230000138282776},{"id":"https://openalex.org/keywords/cell-migration","display_name":"cell migration","score":0.8220000267028809},{"id":"https://openalex.org/keywords/chemokine-signaling","display_name":"chemokine signaling","score":0.796999990940094},{"id":"https://openalex.org/keywords/cxcl12","display_name":"CXCL12","score":0.9610000252723694},{"id":"https://openalex.org/keywords/cxcl13","display_name":"CXCL13","score":0.9559999704360962},{"id":"https://openalex.org/keywords/ccl19","display_name":"CCL19","score":0.9990000128746033},{"id":"https://openalex.org/keywords/lymph-node-homing","display_name":"lymph node homing","score":0.7940000295639038},{"id":"https://openalex.org/keywords/lymphadenopathy","display_name":"lymphadenopathy","score":0.6859999895095825},{"id":"https://openalex.org/keywords/lymphocytosis","display_name":"lymphocytosis","score":0.7049999833106995},{"id":"https://openalex.org/keywords/lymphoma-microenvironment","display_name":"lymphoma microenvironment","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.8328127861022949},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.7895414233207703},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.7541099786758423},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5555334091186523},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5495558381080627},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.537992537021637},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.5173249244689941},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.513585090637207},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.4372180104255676},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3325311541557312},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.24886009097099304},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.24767115712165833},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2231304943561554}],"mesh":[{"descriptor_ui":"D000077329","descriptor_name":"Agammaglobulinaemia Tyrosine Kinase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002448","descriptor_name":"Cell Adhesion","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002465","descriptor_name":"Cell Movement","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005353","descriptor_name":"Fibronectins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011947","descriptor_name":"Receptors, Antigen, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018925","descriptor_name":"Chemokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019010","descriptor_name":"Vascular Cell Adhesion Molecule-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D039041","descriptor_name":"Integrin alpha4beta1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1182/blood-2011-11-390989","doi":"https://doi.org/10.1182/blood-2011-11-390989","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2011-11-390989","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:22279054","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22279054","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Journal Article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/91ba4486-8fdb-4bb4-bbc4-c9a7de4ed1f0","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/the-clinically-active-btk-inhibitor-pci32765-targets-bcell-receptor-and-chemokinecontrolled-adhesion-and-migration-in-chronic-lymphocytic-leukemia(91ba4486-8fdb-4bb4-bbc4-c9a7de4ed1f0).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Blood, 119(11), 2590 - 2594. American Society of Hematology","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/bb1394d5-95bc-4b88-b9cc-c2cd1b5b83eb","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/bb1394d5-95bc-4b88-b9cc-c2cd1b5b83eb","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"de Rooij, M F M, Kuil, A, Geest, C R, Eldering, E, Chang, B Y, Buggy, J J, Pals, S T & Spaargaren, M 2012, 'The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia', Blood, vol. 119, no. 11, pp. 2590-2594. https://doi.org/10.1182/blood-2011-11-390989","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320333648","display_name":"Pharmacyclics","ror":"https://ror.org/03hm8w204"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1925706823","https://openalex.org/W1976058906","https://openalex.org/W1976402300","https://openalex.org/W1976916701","https://openalex.org/W2004264801","https://openalex.org/W2019655196","https://openalex.org/W2022054497","https://openalex.org/W2026234361","https://openalex.org/W2038053631","https://openalex.org/W2046304104","https://openalex.org/W2058786179","https://openalex.org/W2075875145","https://openalex.org/W2095020121","https://openalex.org/W2112701681","https://openalex.org/W2119374469","https://openalex.org/W2134139148","https://openalex.org/W2141836356","https://openalex.org/W2154992334","https://openalex.org/W2155827443","https://openalex.org/W2163690533","https://openalex.org/W2171644620","https://openalex.org/W2242208648","https://openalex.org/W2530008332"],"related_works":["https://openalex.org/W2011950935","https://openalex.org/W2075875145","https://openalex.org/W2106762374","https://openalex.org/W4241158903","https://openalex.org/W2161703402","https://openalex.org/W2588418776","https://openalex.org/W2979995836","https://openalex.org/W2896004685","https://openalex.org/W2573662645","https://openalex.org/W2946520077"],"abstract_inverted_index":{"Small-molecule":[0],"drugs":[1],"that":[2,61,74,115],"target":[3],"the":[4,14,23],"B-cell":[5,17],"antigen":[6],"receptor":[7],"(BCR)":[8],"signalosome":[9],"show":[10,73],"clinical":[11,63],"efficacy":[12],"in":[13,34,133,146],"treatment":[15],"of":[16,46,88,108,117,129],"non-Hodgkin":[18],"lymphoma.":[19],"These":[20],"agents,":[21],"including":[22],"Bruton":[24],"tyrosine":[25],"kinase":[26],"(BTK)":[27],"inhibitor":[28],"PCI-32765,":[29],"display":[30],"an":[31],"unexpected":[32],"response":[33,64],"patients":[35],"with":[36],"chronic":[37],"lymphocytic":[38],"leukemia":[39],"(CLL):":[40],"a":[41],"rapid":[42],"and":[43,80,86,92,102,106,123,127,136,140],"sustained":[44],"reduction":[45],"lymphadenopathy":[47],"accompanied":[48],"by":[49,119],"transient":[50],"lymphocytosis,":[51],"which":[52,144],"is":[53],"reversible":[54],"upon":[55],"temporary":[56],"drug":[57],"deprivation.":[58],"We":[59],"hypothesized":[60],"this":[62],"reflects":[65],"impaired":[66],"integrin-mediated":[67,125],"adhesion":[68,83],"and/or":[69],"migration.":[70],"Here,":[71],"we":[72],"PCI-32765":[75,97,120],"strongly":[76],"inhibits":[77,99],"BCR-controlled":[78],"signaling":[79],"integrin":[81],"\u03b1(4)\u03b2(1)-mediated":[82],"to":[84],"fibronectin":[85],"VCAM-1":[87],"lymphoma":[89],"cell":[90],"lines":[91],"primary":[93,109],"CLL":[94,110,149],"cells.":[95,111],"Furthermore,":[96],"also":[98],"CXCL12-,":[100],"CXCL13-,":[101],"CCL19-induced":[103],"signaling,":[104],"adhesion,":[105],"migration":[107],"Our":[112],"data":[113],"indicate":[114],"inhibition":[116],"BTK":[118],"overcomes":[121],"BCR-":[122],"chemokine-controlled":[124],"retention":[126],"homing":[128],"malignant":[130],"B":[131],"cells":[132],"their":[134],"growth-":[135],"survival-supporting":[137],"lymph":[138],"node":[139],"bone":[141],"marrow":[142],"microenvironment,":[143],"results":[145],"clinically":[147],"evident":[148],"regression.":[150]},"counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":26},{"year":2023,"cited_by_count":28},{"year":2022,"cited_by_count":42},{"year":2021,"cited_by_count":48},{"year":2020,"cited_by_count":42},{"year":2019,"cited_by_count":31},{"year":2018,"cited_by_count":37},{"year":2017,"cited_by_count":44},{"year":2016,"cited_by_count":41},{"year":2015,"cited_by_count":65},{"year":2014,"cited_by_count":55},{"year":2013,"cited_by_count":63},{"year":2012,"cited_by_count":24}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}